Comparative Pharmacology
Head-to-head clinical analysis: COR OTICIN versus MYCHEL S.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COR OTICIN versus MYCHEL S.
COR-OTICIN vs MYCHEL-S
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COR-OTICIN is a combination product containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit) and polymyxin B (a polymyxin antibiotic that disrupts bacterial cell membrane permeability).
Sulconazole inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis and disrupting fungal cell membrane integrity.
1-2 drops in each affected ear twice daily for 7 days.
200 mg orally every 12 hours for 14 days
None Documented
None Documented
Terminal half-life 4-6 hours; prolonged in renal impairment (up to 12-15 hours)
3-4 hours in normal renal function; prolonged to 20-40 hours in severe renal impairment (CrCl <10 mL/min).
Renal (60-80% unchanged), fecal/biliary (5-10%)
Renal: 70-80% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: <5%.
Category C
Category C
Topical Corticosteroid + Antibiotic
Antibiotic